Sutent 欧盟 - 罗马尼亚文 - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agenți antineoplazici - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

MESALAZINA SOFARFARM 400 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mesalazina sofarfarm 400 mg

sofar s.p.a. - italia - mesalazinum - compr. gastrorezistente - 400mg - antiinflamatoare intestinale acid aminosalicilic si alte medicamente similare

MESALAZINA SOFARFARM 800 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mesalazina sofarfarm 800 mg

sofar s.p.a. - italia - mesalazinum - compr. gastrorezistente - 800mg - antiinflamatoare intestinale acid aminosalicilic si alte medicamente similare

Acard 75 mg comprimate gastrorezistente 摩尔多瓦 - 罗马尼亚文 - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

acard 75 mg comprimate gastrorezistente

pharmaceutical works polpharma s.a. - acid acetylsalicylicum - comprimate gastrorezistente - 75 mg

Acard comprimate gastrorezistente 150 mg 摩尔多瓦 - 罗马尼亚文 - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

acard comprimate gastrorezistente 150 mg

pharmaceutical works polpharma s.a. - acid acetylsalicylicum - comprimate gastrorezistente - 150 mg